# Wegovy HD 7.2 mg vs 2.4 mg: weight loss and side effects

Source: https://pepvault.app/guides/wegovy-hd-7-2-mg

Last updated: 2026-11-20

Use: © PepVault. Read and cite with a link. Copying, bulk scraping, rewriting or republishing is not permitted (https://pepvault.app/terms#content).

[Guides](https://pepvault.app/guides) [GLP-1s](https://pepvault.app/guides#glp1)

# Wegovy HD: is 7.2 mg worth it, and what changes from 2.4 mg

Reviewed November 2026 6 sources [Published by PepVault](https://pepvault.app/guides/how-we-research)

Wegovy HD 7.2 mg against 2.4 mg in the STEP UP trials: the extra weight lost, who reached 20% and 25%, the side effects side by side, and who the label allows.

- **Last reviewed:** Nov 20, 2026
- **Sources:** 6
- **Questions:** 7
- **Compounds:** 1

## The short answer

As of November 20, 2026, Wegovy HD (7.2 mg weekly) is for adults who have tolerated 2.4 mg for at least four weeks and whose prescriber judges they need more weight loss. In the 72-week STEP UP trial it averaged an 18.8% loss against 15.5% on 2.4 mg, and 45.5% lost a fifth of their weight against 32.3%. The trade: more vomiting, and skin-sensation changes (22% against 6%, both trials).

Every number checked at its primary source · Nov 20, 2026 · [6 sources](https://pepvault.app/guides/wegovy-hd-7-2-mg#sources) · [How we research](https://pepvault.app/guides/how-we-research)

**Evidence:** Two randomised, double-blind 72-week phase 3b trials in 1,919 adults with obesity, with and without type 2 diabetes (STEP UP and STEP UP T2D, both funded by Novo Nordisk), and the FDA label and approval built on them; the 7.2 mg dose is FDA-approved.

## How much more weight do you lose on 7.2 mg than on 2.4 mg?

About three more points of body weight on average, and a much bigger share of people at the top end. STEP UP randomised 1,407 adults with obesity and no diabetes to 7.2 mg, 2.4 mg or placebo for 72 weeks; at the end, 7.2 mg was ahead of 2.4 mg by 3.3 percentage points, a gap that held up statistically[1](https://pepvault.app/guides/wegovy-hd-7-2-mg#source-1) [3](https://pepvault.app/guides/wegovy-hd-7-2-mg#source-3). For someone starting at 250 pounds, 3.3 points is about 8 pounds. The average undersells the dose, though: the clearer change is how many people reached the big milestones.

| At week 72 | Placebo | Wegovy 2.4 mg | Wegovy HD 7.2 mg |
| --- | --- | --- | --- |
| Average weight change | −3.9%[1](https://pepvault.app/guides/wegovy-hd-7-2-mg#source-1) | −15.5%[1](https://pepvault.app/guides/wegovy-hd-7-2-mg#source-1) | −18.8%[1](https://pepvault.app/guides/wegovy-hd-7-2-mg#source-1) |
| Lost 5% or more | 38.3%[1](https://pepvault.app/guides/wegovy-hd-7-2-mg#source-1) | 86.6%[1](https://pepvault.app/guides/wegovy-hd-7-2-mg#source-1) | 88.7%[1](https://pepvault.app/guides/wegovy-hd-7-2-mg#source-1) |
| Lost 10% or more | 20.3%[1](https://pepvault.app/guides/wegovy-hd-7-2-mg#source-1) | 72%[1](https://pepvault.app/guides/wegovy-hd-7-2-mg#source-1) | 79.8%[1](https://pepvault.app/guides/wegovy-hd-7-2-mg#source-1) |
| Lost 15% or more | 7.5%[1](https://pepvault.app/guides/wegovy-hd-7-2-mg#source-1) | 52.3%[1](https://pepvault.app/guides/wegovy-hd-7-2-mg#source-1) | 63.8%[1](https://pepvault.app/guides/wegovy-hd-7-2-mg#source-1) |
| Lost 20% or more | 2.8%[1](https://pepvault.app/guides/wegovy-hd-7-2-mg#source-1) | 32.3%[1](https://pepvault.app/guides/wegovy-hd-7-2-mg#source-1) | 45.5%[1](https://pepvault.app/guides/wegovy-hd-7-2-mg#source-1) |
| Lost 25% or more (trial registry: only people weighed at week 72) | 0 of 171[5](https://pepvault.app/guides/wegovy-hd-7-2-mg#source-5) | 15.3% (29 of 189)[5](https://pepvault.app/guides/wegovy-hd-7-2-mg#source-5) | 31.2% (296 of 950)[5](https://pepvault.app/guides/wegovy-hd-7-2-mg#source-5) |
| Waist change | −5.6 cm[1](https://pepvault.app/guides/wegovy-hd-7-2-mg#source-1) | −14.2 cm[1](https://pepvault.app/guides/wegovy-hd-7-2-mg#source-1) | −17.5 cm[1](https://pepvault.app/guides/wegovy-hd-7-2-mg#source-1) |

Read the table from the bottom up. Almost everyone on either dose lost 5%, so at that line the extra drug adds little. The doses pull apart at 20% and 25%: twice as many people on 7.2 mg lost a quarter of their body weight[5](https://pepvault.app/guides/wegovy-hd-7-2-mg#source-5). The label's rows count everyone randomised, including people who stopped the drug; the 25% row comes from the trial's posted results and counts only those weighed at week 72, so its percentages run a little higher[1](https://pepvault.app/guides/wegovy-hd-7-2-mg#source-1) [5](https://pepvault.app/guides/wegovy-hd-7-2-mg#source-5). These are group results, not a forecast for one person.

<!--promo-->

PepVault's weigh-in log draws your trend in pounds or kilograms, so the weeks on 2.4 mg and any weeks after a change read side by side. [Track your weight in PepVault](https://apps.apple.com/app/apple-store/id6779318649?ppid=616838ec-3248-400f-bd58-4b93f85f1a20&pt=129020030&ct=guide-wegovy-hd-7-2-mg-inline&mt=8)

<!--/promo-->

<!--promo-->

PepVault for iPhone

## Keep your protocol in PepVault

PepVault's weigh-in log draws your trend in pounds or kilograms, so the weeks on 2.4 mg and any weeks after a change read side by side.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?ppid=616838ec-3248-400f-bd58-4b93f85f1a20&pt=129020030&ct=guide-card-flow&mt=8)

7 days free on the yearly plan for new subscribers.

<!--/promo-->

## What changes in your body when the dose goes up to 7.2 mg?

Three times the drug in your blood. At steady state, the level reached once each weekly dose balances what the body clears, semaglutide averaged about 75 nmol/L on 2.4 mg and about 230 nmol/L on 7.2 mg, and the label says exposure rose in proportion to the dose all the way up[1](https://pepvault.app/guides/wegovy-hd-7-2-mg#source-1). Semaglutide is a GLP-1 receptor agonist: it copies a gut hormone that slows the stomach and quiets hunger signals in the brain, so more of it at the receptor means more of that effect, and more of its side effects.

The step itself is a single jump. Wegovy HD is one 7.2 mg single-dose pen of 0.75 mL, and the label lists no strength between 2.4 mg and 7.2 mg[1](https://pepvault.app/guides/wegovy-hd-7-2-mg#source-1). In both trials the 7.2 mg group climbed the usual ladder, 0.25, 0.5, 1, 1.7 and 2.4 mg, four weeks each, then went to 7.2 mg at week 20[5](https://pepvault.app/guides/wegovy-hd-7-2-mg#source-5) [6](https://pepvault.app/guides/wegovy-hd-7-2-mg#source-6). With a half-life of about a week, each dose stacks on the last, so the new level builds over the following weeks rather than on the day of the step[1](https://pepvault.app/guides/wegovy-hd-7-2-mg#source-1). The chart shows the build.

Try it

How Semaglutide builds up

An estimate from a half-life of about 6.9 days, one dose a week for four weeks. The shape of the level, not a measurement.

[Try your own schedule](https://pepvault.app/tools/peptide-half-life-calculator) [Semaglutide in the library](https://pepvault.app/peptides/semaglutide)

## Which side effects go up at 7.2 mg?

Mostly the same stomach effects as 2.4 mg, a little more often, plus one effect that clearly rises. The label pooled the two trials and listed the effects more common on 7.2 mg than on both 2.4 mg and placebo[1](https://pepvault.app/guides/wegovy-hd-7-2-mg#source-1):

| Effect (both trials pooled) | Placebo | Wegovy 2.4 mg | Wegovy HD 7.2 mg |
| --- | --- | --- | --- |
| Nausea | 13%[1](https://pepvault.app/guides/wegovy-hd-7-2-mg#source-1) | 35%[1](https://pepvault.app/guides/wegovy-hd-7-2-mg#source-1) | 39%[1](https://pepvault.app/guides/wegovy-hd-7-2-mg#source-1) |
| Vomiting | 6%[1](https://pepvault.app/guides/wegovy-hd-7-2-mg#source-1) | 16%[1](https://pepvault.app/guides/wegovy-hd-7-2-mg#source-1) | 22%[1](https://pepvault.app/guides/wegovy-hd-7-2-mg#source-1) |
| Dysesthesia (altered skin sensation) | 0%[1](https://pepvault.app/guides/wegovy-hd-7-2-mg#source-1) | 6%[1](https://pepvault.app/guides/wegovy-hd-7-2-mg#source-1) | 22%[1](https://pepvault.app/guides/wegovy-hd-7-2-mg#source-1) |
| Constipation | 8%[1](https://pepvault.app/guides/wegovy-hd-7-2-mg#source-1) | 19%[1](https://pepvault.app/guides/wegovy-hd-7-2-mg#source-1) | 20%[1](https://pepvault.app/guides/wegovy-hd-7-2-mg#source-1) |
| Belly pain | 7%[1](https://pepvault.app/guides/wegovy-hd-7-2-mg#source-1) | 9%[1](https://pepvault.app/guides/wegovy-hd-7-2-mg#source-1) | 12%[1](https://pepvault.app/guides/wegovy-hd-7-2-mg#source-1) |
| Tiredness | 5%[1](https://pepvault.app/guides/wegovy-hd-7-2-mg#source-1) | 9%[1](https://pepvault.app/guides/wegovy-hd-7-2-mg#source-1) | 11%[1](https://pepvault.app/guides/wegovy-hd-7-2-mg#source-1) |
| Hair loss | 1%[1](https://pepvault.app/guides/wegovy-hd-7-2-mg#source-1) | 3%[1](https://pepvault.app/guides/wegovy-hd-7-2-mg#source-1) | 6%[1](https://pepvault.app/guides/wegovy-hd-7-2-mg#source-1) |
| Stopped for a side effect | 2%[1](https://pepvault.app/guides/wegovy-hd-7-2-mg#source-1) | 5%[1](https://pepvault.app/guides/wegovy-hd-7-2-mg#source-1) | 5%[1](https://pepvault.app/guides/wegovy-hd-7-2-mg#source-1) |

The bottom row is the one people underrate: the share who quit because of side effects was the same on both doses, 5%, and stomach effects made up 3 points of it in each[1](https://pepvault.app/guides/wegovy-hd-7-2-mg#source-1). Serious adverse events in STEP UP were 6.8% on 7.2 mg, 10.9% on 2.4 mg and 5.5% on placebo[3](https://pepvault.app/guides/wegovy-hd-7-2-mg#source-3). Hair loss nearly doubled, and it fell almost entirely on women: 8.4% of women on 7.2 mg against 5.4% on 2.4 mg, and 0.2% of men[1](https://pepvault.app/guides/wegovy-hd-7-2-mg#source-1). The semaglutide side-effects page and our Ozempic and Wegovy side-effects guide cover what helps with each stomach effect.

**Commonly reported:** a few days of stronger nausea or fullness after the first 7.2 mg pens, settling over the following weeks, and skin that feels sore, prickly or sunburnt on 7.2 mg.

**When to get help** Belly pain that is severe and will not go away, with or without vomiting, is the label's reason to stop Wegovy and call your prescriber right away[1](https://pepvault.app/guides/wegovy-hd-7-2-mg#source-1).

## With this guide

### Semaglutide

- [Semaglutide: the full reference](https://pepvault.app/peptides/semaglutide)
- [Semaglutide dose guide](https://pepvault.app/lab/dosage/semaglutide)

### Mixing charts

- [2 mg vial](https://pepvault.app/tools/reconstitution-calculator/semaglutide-2mg)
- [5 mg vial](https://pepvault.app/tools/reconstitution-calculator/semaglutide-5mg)
- [10 mg vial](https://pepvault.app/tools/reconstitution-calculator/semaglutide-10mg)

### Studies

- [Semaglutide: 11.85% more weight loss than placebo without diabetes](https://pepvault.app/research/semaglutide-tan-2022)
- [CagriSema: 18.4% weight loss vs 11.9% on semaglutide in REDEFINE 5](https://pepvault.app/research/cagrisema-redefine-5-2026)
- [CagriSema: HbA1c down 2.33% at 40 weeks in REIMAGINE 3](https://pepvault.app/research/cagrisema-reimagine-3-2026)
- [All 31 studies](https://pepvault.app/research#semaglutide)

### Compared with

- [Semaglutide vs Tirzepatide](https://pepvault.app/peptides/compare/semaglutide-vs-tirzepatide)
- [Retatrutide vs Semaglutide](https://pepvault.app/peptides/compare/retatrutide-vs-semaglutide)
- [Orforglipron vs Semaglutide](https://pepvault.app/peptides/compare/orforglipron-vs-semaglutide)
- [Cagrilintide vs Semaglutide](https://pepvault.app/peptides/compare/cagrilintide-vs-semaglutide)
- [Liraglutide vs Semaglutide](https://pepvault.app/peptides/compare/liraglutide-vs-semaglutide)
- [Semaglutide vs Dulaglutide](https://pepvault.app/peptides/compare/semaglutide-vs-dulaglutide)

### Tools

- [Reconstitution calculator](https://pepvault.app/tools/reconstitution-calculator)
- [How long will my vial last?](https://pepvault.app/tools/how-long-will-my-vial-last)
- [Is my mixed vial still good?](https://pepvault.app/tools/reconstituted-peptide-expiry)
- [Half-life calculator](https://pepvault.app/tools/peptide-half-life-calculator)
- [GLP-1 titration planner](https://pepvault.app/tools/glp1-titration-calculator)
- [GLP-1 weight loss by week](https://pepvault.app/tools/glp1-weight-loss-by-week)

### The GLP-1 path

- [Retatrutide week by week](https://pepvault.app/guides/retatrutide-week-by-week)
- [Retatrutide dosage: the trial step-ups](https://pepvault.app/guides/retatrutide-dosage-in-trials)
- [Tirzepatide week by week](https://pepvault.app/guides/tirzepatide-week-by-week)
- [Semaglutide week by week](https://pepvault.app/guides/semaglutide-week-by-week)
- [Tirzepatide dosage: every step from 2.5 to 15 mg (Mounjaro and Zepbound)](https://pepvault.app/guides/tirzepatide-dosage)
- [Wegovy and Ozempic dosage: both labels' steps in one table, and why the two differ](https://pepvault.app/guides/wegovy-and-ozempic-dosage)
- [How to use the Zepbound KwikPen](https://pepvault.app/guides/how-to-use-the-zepbound-kwikpen)
- [How to use the Ozempic and Wegovy pens: needles, the dose counter and clicks](https://pepvault.app/guides/how-to-use-ozempic-and-wegovy-pens)
- [What time of day to take your GLP-1 shot or pill, and can you change the day?](https://pepvault.app/guides/when-to-take-your-glp-1)
- [Switching GLP-1s: Ozempic to Zepbound, shot to pill, and what the trials tested](https://pepvault.app/guides/switching-between-glp-1s)
- [Ozempic vs Wegovy vs Mounjaro vs Zepbound: the four labels in one table](https://pepvault.app/guides/ozempic-wegovy-mounjaro-zepbound)
- [Is Ozempic insulin? GLP-1, GIP and insulin explained](https://pepvault.app/guides/is-ozempic-insulin)
- [The Wegovy pill: what it is, how its label differs from the shot, and the trial numbers](https://pepvault.app/guides/the-wegovy-pill)
- [Ozempic and Wegovy side effects: what the trials counted and when they showed up](https://pepvault.app/guides/ozempic-and-wegovy-side-effects)
- [Semaglutide vs tirzepatide side effects: what the head-to-head trials found](https://pepvault.app/guides/sema-vs-tirzepatide-side-effects)
- [Microdosing a GLP-1: what it means and what has been tested](https://pepvault.app/guides/microdosing-a-glp-1)
- [GLP-1s and sleep apnea: Zepbound's OSA approval](https://pepvault.app/guides/glp-1-and-sleep-apnea)
- [Retatrutide first dose: the first four weeks in the trials](https://pepvault.app/guides/retatrutide-first-dose)
- [Retatrutide side effects: what the trials counted](https://pepvault.app/guides/retatrutide-side-effects)
- [Retatrutide not working? Stalls, slow responders and the plateau](https://pepvault.app/guides/retatrutide-not-working)
- [Switching from tirzepatide to retatrutide: what is known](https://pepvault.app/guides/tirzepatide-to-retatrutide)
- [Is retatrutide safe? What the trials reported](https://pepvault.app/guides/is-retatrutide-safe)
- [When will retatrutide be approved?](https://pepvault.app/guides/when-will-retatrutide-be-approved)
- [TRIUMPH-5 results: retatrutide vs tirzepatide head to head](https://pepvault.app/guides/triumph-5-results)
- [CagriSema FDA approval: when it's due, the dose filed, and what the trials showed](https://pepvault.app/guides/cagrisema-fda-decision)
- [MariTide phase 3 results (MARITIME-1): what to expect](https://pepvault.app/guides/maritime-1-results)
- [Aleniglipron: the GLP-1 pill, and the trial switching people from shots to it](https://pepvault.app/guides/aleniglipron-switch-trial)
- [Mounjaro and Zepbound side effects by dose: the rates at each step](https://pepvault.app/guides/mounjaro-zepbound-side-effects)
- [Hair loss on a GLP-1: how common it is per drug, and why](https://pepvault.app/guides/hair-loss-on-a-glp-1)
- ["Ozempic face": what it is, and where the weight comes from](https://pepvault.app/guides/ozempic-face)
- [Foundayo (orforglipron) vs the shots: the trial numbers side by side](https://pepvault.app/guides/foundayo-vs-the-shots)
- [Is compounded semaglutide or tirzepatide the same as Ozempic or Zepbound?](https://pepvault.app/guides/compounded-glp-1-vs-brand)
- [Why compounded semaglutide and tirzepatide come with B12, glycine or B6, and what it changes](https://pepvault.app/guides/compounded-glp-1-with-b12)
- [Is there a generic Ozempic? Generic semaglutide and Sevmia](https://pepvault.app/guides/generic-semaglutide)
- [How much does a GLP-1 cost in 2026? Zepbound, Wegovy and Medicare prices](https://pepvault.app/guides/how-much-does-a-glp-1-cost)
- [What to eat on a GLP-1: what the trials and the guidelines say](https://pepvault.app/guides/what-to-eat-on-a-glp-1)
- [How much protein per day? The numbers by weight and goal](https://pepvault.app/guides/how-much-protein-per-day)
- [Muscle on a GLP-1: how much of the weight lost is lean mass?](https://pepvault.app/guides/muscle-on-a-glp-1)
- [Intermittent fasting on a GLP-1: what the trials and labels say](https://pepvault.app/guides/intermittent-fasting-on-a-glp-1)
- [Coffee on a GLP-1: can you drink it, and why it can taste different](https://pepvault.app/guides/coffee-on-a-glp-1)
- [Food noise on a GLP-1: what it is and what happens after stopping](https://pepvault.app/guides/food-noise-on-a-glp-1)
- [GLP-1s and menopause: what the trials say about women in midlife](https://pepvault.app/guides/glp-1s-and-menopause)
- [Stopping a GLP-1: what happens to your weight](https://pepvault.app/guides/stopping-a-glp-1)
- [How to keep the weight off after a GLP-1: what each trial tested](https://pepvault.app/guides/keeping-weight-off-after-a-glp-1)
- [Berberine vs metformin vs a GLP-1: what each does to weight and glucose](https://pepvault.app/guides/berberine-vs-metformin-vs-glp-1)
- [Natural GLP-1 alternatives: what the evidence shows for berberine, fiber and supplements](https://pepvault.app/guides/natural-glp-1-alternatives)
- [What is 5-Amino-1MQ? What's been measured](https://pepvault.app/guides/5-amino-1mq-explained)
- [Retatrutide from a lab vial: what independent testing found](https://pepvault.app/guides/retatrutide-lab-vial-tests)
- [Switching from Saxenda to Wegovy: how the change works](https://pepvault.app/guides/saxenda-to-wegovy)
- [Do you stop Ozempic, Wegovy, Mounjaro or Zepbound before surgery?](https://pepvault.app/guides/glp-1-before-surgery)
- [Diarrhea on a GLP-1: how common, and how long it lasts](https://pepvault.app/guides/diarrhea-on-a-glp-1)
- [Dizziness on a GLP-1: dehydration, blood pressure or blood sugar?](https://pepvault.app/guides/dizziness-on-a-glp-1)
- [Heartburn and acid reflux on a GLP-1: the rates, the timing and what helps](https://pepvault.app/guides/heartburn-on-a-glp-1)
- [Does Ozempic or Mounjaro make you tired? Fatigue in the trials](https://pepvault.app/guides/glp-1-fatigue)
- [Can a GLP-1 cause low blood sugar if you do not have diabetes?](https://pepvault.app/guides/glp-1-low-blood-sugar)
- [Is there a medicine for GLP-1 nausea? Tradipitant, so far](https://pepvault.app/guides/tradipitant-for-glp-1-nausea)
- [GLP-1s and mood: depression, anxiety and what the FDA review found](https://pepvault.app/guides/glp-1s-and-mood)
- [Can Ozempic cause vision loss? GLP-1s and NAION, by the numbers](https://pepvault.app/guides/glp-1-and-naion)
- [Are GLP-1s safe long term? What the longest trials show](https://pepvault.app/guides/are-glp-1s-safe-long-term)
- [GLP-1s and the kidneys: what FLOW showed, and the dehydration risk](https://pepvault.app/guides/glp-1s-and-the-kidneys)
- [Can you drink alcohol on Ozempic, Mounjaro or another GLP-1?](https://pepvault.app/guides/alcohol-on-a-glp-1)
- [Do GLP-1s reduce alcohol cravings? What the trials found](https://pepvault.app/guides/glp-1-and-alcohol-cravings)
- [GLP-1s and fatty liver: what the trials measured](https://pepvault.app/guides/glp-1-and-fatty-liver)
- [GLP-1s after a gastric sleeve or bypass: regain, dosing and sleeve vs GLP-1](https://pepvault.app/guides/glp-1-after-bariatric-surgery)
- [Can you drink alcohol on retatrutide?](https://pepvault.app/guides/retatrutide-and-alcohol)
- [Ozempic, Wegovy, Mounjaro or Zepbound not working? Slow responders and plateaus in the trials](https://pepvault.app/guides/glp-1-not-working)
- [Intermittent fasting for weight and fat loss: what the trials measured](https://pepvault.app/guides/intermittent-fasting-weight-loss)
- [Can you take metformin with Ozempic, Mounjaro or another GLP-1?](https://pepvault.app/guides/metformin-with-a-glp-1)
- [GLP-1s and pregnancy: Ozempic, Wegovy, Mounjaro and Zepbound before and during](https://pepvault.app/guides/glp-1s-and-pregnancy)
- [Can you take Ozempic, Mounjaro or another GLP-1 while breastfeeding?](https://pepvault.app/guides/glp-1-while-breastfeeding)
- [Eloralintide, petrelintide and amycretin: the amylin drugs in trials](https://pepvault.app/guides/amylin-drugs-in-trials)
- [Olatorepatide (HS-20094): Regeneron's obesity drug, what is known so far](https://pepvault.app/guides/olatorepatide-explained)
- [Cagrilintide and CagriSema: what amylin adds to semaglutide](https://pepvault.app/guides/cagrilintide-and-cagrisema)
- [Berobenatide (PF-08653944, MET-097i): Pfizer's monthly GLP-1 shot, what is known so far](https://pepvault.app/guides/berobenatide-explained)
- [The GLP-1 pipeline: every drug in phase 2 and 3, and when its trials finish](https://pepvault.app/guides/glp-1-pipeline)
- [Is there a monthly GLP-1 shot? MariTide and berobenatide](https://pepvault.app/guides/monthly-glp-1-shots)
- [Cagrilintide alone: RENEW 1 phase 3 results and what to expect](https://pepvault.app/guides/renew-1-cagrilintide-results)
- [Zenagamtide (amycretin): Novo's GLP-1 and amylin shot and pill, what the trials show](https://pepvault.app/guides/zenagamtide-amycretin)
- [Wegovy and Ozempic price, Medicare and WADA: what changes on January 1, 2027](https://pepvault.app/guides/glp-1-changes-january-2027)
- [Can you take sermorelin with Ozempic, Mounjaro or another GLP-1?](https://pepvault.app/guides/sermorelin-with-a-glp-1)
- [Retatrutide in women: what the studies included](https://pepvault.app/guides/retatrutide-in-women)
- [Peptides for women: what the trials in women show, and after 40](https://pepvault.app/guides/peptides-for-women)
- [Low-dose naltrexone (LDN) for weight loss: what the trials measured](https://pepvault.app/guides/ldn-for-weight-loss)
- [GLP-1s and PCOS: what the trials show, and how they compare with metformin](https://pepvault.app/guides/glp-1-and-pcos)
- [GLP-1s and sleep: insomnia, vivid dreams and the sleep apnea approval](https://pepvault.app/guides/glp-1s-and-sleep)

### Terms on this page

- [Receptor agonist](https://pepvault.app/glossary/receptor-agonist)
- [Half-life](https://pepvault.app/glossary/half-life)
- [Steady state](https://pepvault.app/glossary/steady-state)
- [Maintenance dose](https://pepvault.app/glossary/maintenance-dose)
- [Stack](https://pepvault.app/glossary/stack)
- [GLP-1](https://pepvault.app/glossary/glp-1)
- [Placebo](https://pepvault.app/glossary/placebo)
- [Indication](https://pepvault.app/glossary/indication)

## What is dysesthesia on Wegovy, and does it go away?

Dysesthesia is skin that feels wrong: tingling, burning, prickling, or touch that hurts more than it should. The label groups pins and needles, skin pain, sensitive skin and burning skin under the term, and says it grew with the dose and with the drug level in the blood[1](https://pepvault.app/guides/wegovy-hd-7-2-mg#source-1). It is the one side effect that sets 7.2 mg apart: 22% on 7.2 mg, 6% on 2.4 mg and 0.3% on placebo across the two trials[1](https://pepvault.app/guides/wegovy-hd-7-2-mg#source-1).

Most of it resolved, usually after the dose was paused or lowered; the side-effects guide has the full count[1](https://pepvault.app/guides/wegovy-hd-7-2-mg#source-1). What matters for the step: of 38 people who recovered and then went back up to 7.2 mg, 17 (45%) had it again[1](https://pepvault.app/guides/wegovy-hd-7-2-mg#source-1). The FDA's approval letter requires Novo Nordisk to track dysesthesia as a named safety event, case by case, in a further trial of 7.2 mg against 2.4 mg[2](https://pepvault.app/guides/wegovy-hd-7-2-mg#source-2).

<!--promo-->

PepVault's side-effect log records each symptom with its date and severity, including one you name yourself, such as skin tingling, so its pattern after each dose is there to show your prescriber. [Log it in PepVault](https://apps.apple.com/app/apple-store/id6779318649?ppid=616838ec-3248-400f-bd58-4b93f85f1a20&pt=129020030&ct=guide-wegovy-hd-7-2-mg-inline&mt=8)

<!--/promo-->

## Does 7.2 mg work as well if you have type 2 diabetes?

It works, from a lower starting point. STEP UP T2D randomised 512 adults with obesity and type 2 diabetes (HbA1c 7 to 10%) for 72 weeks[4](https://pepvault.app/guides/wegovy-hd-7-2-mg#source-4). Weight fell 13.2% on 7.2 mg, 10.4% on 2.4 mg and 3.8% on placebo; 20.6% lost a fifth of their weight on 7.2 mg against 13.5% on 2.4 mg[1](https://pepvault.app/guides/wegovy-hd-7-2-mg#source-1). The label marks the 2.4 mg results in this trial as informative only, because the trial was built to test 7.2 mg against placebo[1](https://pepvault.app/guides/wegovy-hd-7-2-mg#source-1) [4](https://pepvault.app/guides/wegovy-hd-7-2-mg#source-4).

Blood sugar barely separated the doses: HbA1c, the three-month sugar average, fell 1.7 points on 7.2 mg and 1.6 on 2.4 mg[1](https://pepvault.app/guides/wegovy-hd-7-2-mg#source-1). Stomach effects were close too, 53.1% against 51.5%, and the authors judged the two doses alike in tolerability apart from dysesthesia, 18.9% against 4.9%[4](https://pepvault.app/guides/wegovy-hd-7-2-mg#source-4). Low blood sugar of the serious kinds was rare and similar across the three groups[4](https://pepvault.app/guides/wegovy-hd-7-2-mg#source-4).

## Who can be prescribed Wegovy HD?

The FDA approved the 7.2 mg dose on March 19, 2026, as a new dose for weight reduction and keeping it off long term[2](https://pepvault.app/guides/wegovy-hd-7-2-mg#source-2). As of November 20, 2026, the label's rules are these[1](https://pepvault.app/guides/wegovy-hd-7-2-mg#source-1):

- **Adults only.** Safety and effectiveness of 7.2 mg are not established in children; the FDA has required trials in 6- to 17-year-olds who still need weight loss after 2.4 mg[1](https://pepvault.app/guides/wegovy-hd-7-2-mg#source-1) [2](https://pepvault.app/guides/wegovy-hd-7-2-mg#source-2).
- **After 2.4 mg, not instead of it:** for people who tolerate 2.4 mg for at least four weeks and for whom more weight reduction is clinically indicated[1](https://pepvault.app/guides/wegovy-hd-7-2-mg#source-1).
- **For weight, not the other uses.** For heart-risk reduction the maintenance dose stays 2.4 mg or 1.7 mg, and 7.2 mg is not established for the liver disease MASH[1](https://pepvault.app/guides/wegovy-hd-7-2-mg#source-1).
- **Tested at a BMI of 30 or more.** The 7.2 mg line sits under weight reduction in adults, an indication that also covers overweight with a weight-related condition, but both trials enrolled only adults with obesity[1](https://pepvault.app/guides/wegovy-hd-7-2-mg#source-1) [3](https://pepvault.app/guides/wegovy-hd-7-2-mg#source-3) [4](https://pepvault.app/guides/wegovy-hd-7-2-mg#source-4).

Whether to move from 2.4 mg to 7.2 mg is the prescriber's call; the label asks them to weigh treatment response and tolerability[1](https://pepvault.app/guides/wegovy-hd-7-2-mg#source-1). How to use the HD pen is in our guide to the Ozempic and Wegovy pens, the full dose ladder in Wegovy and Ozempic dosage, and the label at a glance at pepvault.app/drugs/wegovy.

## Will 7.2 mg break a plateau on 2.4 mg?

No trial has tested that yet. STEP UP and STEP UP T2D assigned people to 7.2 mg or 2.4 mg on day one and climbed both groups the same way[3](https://pepvault.app/guides/wegovy-hd-7-2-mg#source-3) [4](https://pepvault.app/guides/wegovy-hd-7-2-mg#source-4) [6](https://pepvault.app/guides/wegovy-hd-7-2-mg#source-6); nobody was moved up because they had stalled. So the trials show that, for a group, the 7.2 mg dose ends 72 weeks lower than 2.4 mg. They do not show how much someone who has stopped losing on 2.4 mg will lose after the step. The label's wording, more weight reduction when clinically indicated in people who tolerate 2.4 mg, describes who may be moved up and leaves the judgement to the prescriber[1](https://pepvault.app/guides/wegovy-hd-7-2-mg#source-1).

What a prescriber weighs is mostly what you bring. These are the records that make the conversation short:

1. Pull up your weight trend for the last 8 to 12 weeks on 2.4 mg, so the plateau is a line, not a feeling.
2. List the side effects you have had on 2.4 mg, how often and how strong, since the label's test is that you tolerate 2.4 mg.
3. Note any missed or late doses: after two or more missed in a row, the label restarts the climb lower, which can look like a stall[1](https://pepvault.app/guides/wegovy-hd-7-2-mg#source-1).
4. Ask what the step changes for you: the trials' extra three points on average, a twice-as-likely 25% loss, and about one in five people with skin sensations[1](https://pepvault.app/guides/wegovy-hd-7-2-mg#source-1) [5](https://pepvault.app/guides/wegovy-hd-7-2-mg#source-5).

Why a plateau happens, and what the trials say about slow responders on every GLP-1, is in our guide on GLP-1s that seem not to work.

<!--promo-->

[Track it in the app](https://apps.apple.com/app/apple-store/id6779318649?ppid=616838ec-3248-400f-bd58-4b93f85f1a20&pt=129020030&ct=guide-card-next&mt=8)

<!--/promo-->

## Sources

1. WEGOVY (semaglutide) injection and tablets prescribing information, DailyMed SPL version 19 (updated June 18, 2026; published June 30, 2026), read November 20, 2026 [dailymed.nlm.nih.gov](https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ee06186f-2aa3-4990-a760-757579d8f77b)
2. US FDA. Supplement approval letter, NDA 215256/S-029 and NDA 218316/S-005 (Wegovy injection 7.2 mg weekly dose), March 19, 2026 [accessdata.fda.gov](https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2026/215256Orig1s029;218316Orig1s005ltr.pdf)
3. Wharton S et al.; STEP UP trial group. Once-weekly semaglutide 7.2 mg in adults with obesity (STEP UP): a randomised, controlled, phase 3b trial. Lancet Diabetes Endocrinol. 2025;13(11):949-963. [PubMed 40961952](https://pubmed.ncbi.nlm.nih.gov/40961952/)
4. Lingvay I et al.; STEP UP T2D trial group. Once-weekly semaglutide 7.2 mg in adults with obesity and type 2 diabetes (STEP UP T2D): a randomised, controlled, phase 3b trial. Lancet Diabetes Endocrinol. 2025;13(11):935-948. [PubMed 40961953](https://pubmed.ncbi.nlm.nih.gov/40961953/)
5. ClinicalTrials.gov NCT05646706 (STEP UP), Novo Nordisk A/S: arms and posted results, read November 20, 2026 [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05646706)
6. ClinicalTrials.gov NCT05649137 (STEP UP T2D), Novo Nordisk A/S: arms and posted results, read November 20, 2026 [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05649137)

<!--promo-->

Newsletter · Weekly

## The weekly peptide briefing.

New guides, the week’s peptide news, one tool. Free, one email a week, unsubscribe anytime.

<!--/promo-->

## Next guide · GLP-1

Guide · GLP-1

### [Zenagamtide (amycretin): Novo's GLP-1 and amylin shot and pill, what the trials show](https://pepvault.app/guides/zenagamtide-amycretin)

Zenagamtide is amycretin's official name: Novo's one-molecule GLP-1 and amylin drug. The trial results, all 36 registry trials and when phase 3 data is due.

Read the next guide

<!--promo-->

PepVault for iPhone

## Keep your protocol in PepVault

Log every dose, track every vial, and see your protocol come together.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?ppid=616838ec-3248-400f-bd58-4b93f85f1a20&pt=129020030&ct=guide-card-end&mt=8)

7 days free on the yearly plan for new subscribers.

[Explore the live demo](https://pepvault.app/login)

<!--/promo-->

## In the library

- [Semaglutide Studied range: 0.25–2.4 mg](https://pepvault.app/peptides/semaglutide)

## Related guides

- Guide · GLP-1s

  ### [Ozempic, Wegovy, Mounjaro or Zepbound not working? Slow responders and plateaus in the trials](https://pepvault.app/guides/glp-1-not-working)

  GLP-1 not working? The four labels side by side: how many lost under 5% in the trials, why diabetes slows loss, slow starters, and what a higher dose did.

  Read the guide
- Guide · GLP-1s

  ### [Wegovy and Ozempic dosage: both labels' steps in one table, and why the two differ](https://pepvault.app/guides/wegovy-and-ozempic-dosage)

  Wegovy and Ozempic dosage side by side: both FDA labels' four-week steps, the maintenance doses and the max, why they differ and what the trials saw per dose.

  Read the guide
- Guide · GLP-1s

  ### [Ozempic and Wegovy side effects: what the trials counted and when they showed up](https://pepvault.app/guides/ozempic-and-wegovy-side-effects)

  Ozempic and Wegovy side effects from the labels' trials, drug against placebo: nausea and the rest, when they start, how many days they last, and what helps.

  Read the guide
- Guide · GLP-1s

  ### [How to use the Ozempic and Wegovy pens: needles, the dose counter and clicks](https://pepvault.app/guides/how-to-use-ozempic-and-wegovy-pens)

  The Ozempic pen and each Wegovy pen step by step from the FDA instructions: the needle, the flow check, the dose counter, what the clicks mean, storage, fixes.

  Read the guide

## Guides

- [All guides](https://pepvault.app/guides)
- [How we research](https://pepvault.app/guides/how-we-research)

<!--promo-->

PepVault for iPhone

## Keep your protocol in PepVault

Log every dose, track every vial, and see your protocol come together.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?ppid=616838ec-3248-400f-bd58-4b93f85f1a20&pt=129020030&ct=guide-card-rail&mt=8)

7 days free on the yearly plan for new subscribers.

<!--/promo-->

## With this guide

### Semaglutide

- [Semaglutide: the full reference](https://pepvault.app/peptides/semaglutide)
- [Semaglutide dose guide](https://pepvault.app/lab/dosage/semaglutide)

### Mixing charts

- [2 mg vial](https://pepvault.app/tools/reconstitution-calculator/semaglutide-2mg)
- [5 mg vial](https://pepvault.app/tools/reconstitution-calculator/semaglutide-5mg)
- [10 mg vial](https://pepvault.app/tools/reconstitution-calculator/semaglutide-10mg)

### Studies

- [Semaglutide: 11.85% more weight loss than placebo without diabetes](https://pepvault.app/research/semaglutide-tan-2022)
- [CagriSema: 18.4% weight loss vs 11.9% on semaglutide in REDEFINE 5](https://pepvault.app/research/cagrisema-redefine-5-2026)
- [CagriSema: HbA1c down 2.33% at 40 weeks in REIMAGINE 3](https://pepvault.app/research/cagrisema-reimagine-3-2026)
- [All 31 studies](https://pepvault.app/research#semaglutide)

### Compared with

- [Semaglutide vs Tirzepatide](https://pepvault.app/peptides/compare/semaglutide-vs-tirzepatide)
- [Retatrutide vs Semaglutide](https://pepvault.app/peptides/compare/retatrutide-vs-semaglutide)
- [Orforglipron vs Semaglutide](https://pepvault.app/peptides/compare/orforglipron-vs-semaglutide)
- [Cagrilintide vs Semaglutide](https://pepvault.app/peptides/compare/cagrilintide-vs-semaglutide)
- [Liraglutide vs Semaglutide](https://pepvault.app/peptides/compare/liraglutide-vs-semaglutide)
- [Semaglutide vs Dulaglutide](https://pepvault.app/peptides/compare/semaglutide-vs-dulaglutide)

### Tools

- [Reconstitution calculator](https://pepvault.app/tools/reconstitution-calculator)
- [How long will my vial last?](https://pepvault.app/tools/how-long-will-my-vial-last)
- [Is my mixed vial still good?](https://pepvault.app/tools/reconstituted-peptide-expiry)
- [Half-life calculator](https://pepvault.app/tools/peptide-half-life-calculator)
- [GLP-1 titration planner](https://pepvault.app/tools/glp1-titration-calculator)
- [GLP-1 weight loss by week](https://pepvault.app/tools/glp1-weight-loss-by-week)

### The GLP-1 path

- [Retatrutide week by week](https://pepvault.app/guides/retatrutide-week-by-week)
- [Retatrutide dosage: the trial step-ups](https://pepvault.app/guides/retatrutide-dosage-in-trials)
- [Tirzepatide week by week](https://pepvault.app/guides/tirzepatide-week-by-week)
- [Semaglutide week by week](https://pepvault.app/guides/semaglutide-week-by-week)
- [Tirzepatide dosage: every step from 2.5 to 15 mg (Mounjaro and Zepbound)](https://pepvault.app/guides/tirzepatide-dosage)
- [Wegovy and Ozempic dosage: both labels' steps in one table, and why the two differ](https://pepvault.app/guides/wegovy-and-ozempic-dosage)
- [How to use the Zepbound KwikPen](https://pepvault.app/guides/how-to-use-the-zepbound-kwikpen)
- [How to use the Ozempic and Wegovy pens: needles, the dose counter and clicks](https://pepvault.app/guides/how-to-use-ozempic-and-wegovy-pens)
- [What time of day to take your GLP-1 shot or pill, and can you change the day?](https://pepvault.app/guides/when-to-take-your-glp-1)
- [Switching GLP-1s: Ozempic to Zepbound, shot to pill, and what the trials tested](https://pepvault.app/guides/switching-between-glp-1s)
- [Ozempic vs Wegovy vs Mounjaro vs Zepbound: the four labels in one table](https://pepvault.app/guides/ozempic-wegovy-mounjaro-zepbound)
- [Is Ozempic insulin? GLP-1, GIP and insulin explained](https://pepvault.app/guides/is-ozempic-insulin)
- [The Wegovy pill: what it is, how its label differs from the shot, and the trial numbers](https://pepvault.app/guides/the-wegovy-pill)
- [Ozempic and Wegovy side effects: what the trials counted and when they showed up](https://pepvault.app/guides/ozempic-and-wegovy-side-effects)
- [Semaglutide vs tirzepatide side effects: what the head-to-head trials found](https://pepvault.app/guides/sema-vs-tirzepatide-side-effects)
- [Microdosing a GLP-1: what it means and what has been tested](https://pepvault.app/guides/microdosing-a-glp-1)
- [GLP-1s and sleep apnea: Zepbound's OSA approval](https://pepvault.app/guides/glp-1-and-sleep-apnea)
- [Retatrutide first dose: the first four weeks in the trials](https://pepvault.app/guides/retatrutide-first-dose)
- [Retatrutide side effects: what the trials counted](https://pepvault.app/guides/retatrutide-side-effects)
- [Retatrutide not working? Stalls, slow responders and the plateau](https://pepvault.app/guides/retatrutide-not-working)
- [Switching from tirzepatide to retatrutide: what is known](https://pepvault.app/guides/tirzepatide-to-retatrutide)
- [Is retatrutide safe? What the trials reported](https://pepvault.app/guides/is-retatrutide-safe)
- [When will retatrutide be approved?](https://pepvault.app/guides/when-will-retatrutide-be-approved)
- [TRIUMPH-5 results: retatrutide vs tirzepatide head to head](https://pepvault.app/guides/triumph-5-results)
- [CagriSema FDA approval: when it's due, the dose filed, and what the trials showed](https://pepvault.app/guides/cagrisema-fda-decision)
- [MariTide phase 3 results (MARITIME-1): what to expect](https://pepvault.app/guides/maritime-1-results)
- [Aleniglipron: the GLP-1 pill, and the trial switching people from shots to it](https://pepvault.app/guides/aleniglipron-switch-trial)
- [Mounjaro and Zepbound side effects by dose: the rates at each step](https://pepvault.app/guides/mounjaro-zepbound-side-effects)
- [Hair loss on a GLP-1: how common it is per drug, and why](https://pepvault.app/guides/hair-loss-on-a-glp-1)
- ["Ozempic face": what it is, and where the weight comes from](https://pepvault.app/guides/ozempic-face)
- [Foundayo (orforglipron) vs the shots: the trial numbers side by side](https://pepvault.app/guides/foundayo-vs-the-shots)
- [Is compounded semaglutide or tirzepatide the same as Ozempic or Zepbound?](https://pepvault.app/guides/compounded-glp-1-vs-brand)
- [Why compounded semaglutide and tirzepatide come with B12, glycine or B6, and what it changes](https://pepvault.app/guides/compounded-glp-1-with-b12)
- [Is there a generic Ozempic? Generic semaglutide and Sevmia](https://pepvault.app/guides/generic-semaglutide)
- [How much does a GLP-1 cost in 2026? Zepbound, Wegovy and Medicare prices](https://pepvault.app/guides/how-much-does-a-glp-1-cost)
- [What to eat on a GLP-1: what the trials and the guidelines say](https://pepvault.app/guides/what-to-eat-on-a-glp-1)
- [How much protein per day? The numbers by weight and goal](https://pepvault.app/guides/how-much-protein-per-day)
- [Muscle on a GLP-1: how much of the weight lost is lean mass?](https://pepvault.app/guides/muscle-on-a-glp-1)
- [Intermittent fasting on a GLP-1: what the trials and labels say](https://pepvault.app/guides/intermittent-fasting-on-a-glp-1)
- [Coffee on a GLP-1: can you drink it, and why it can taste different](https://pepvault.app/guides/coffee-on-a-glp-1)
- [Food noise on a GLP-1: what it is and what happens after stopping](https://pepvault.app/guides/food-noise-on-a-glp-1)
- [GLP-1s and menopause: what the trials say about women in midlife](https://pepvault.app/guides/glp-1s-and-menopause)
- [Stopping a GLP-1: what happens to your weight](https://pepvault.app/guides/stopping-a-glp-1)
- [How to keep the weight off after a GLP-1: what each trial tested](https://pepvault.app/guides/keeping-weight-off-after-a-glp-1)
- [Berberine vs metformin vs a GLP-1: what each does to weight and glucose](https://pepvault.app/guides/berberine-vs-metformin-vs-glp-1)
- [Natural GLP-1 alternatives: what the evidence shows for berberine, fiber and supplements](https://pepvault.app/guides/natural-glp-1-alternatives)
- [What is 5-Amino-1MQ? What's been measured](https://pepvault.app/guides/5-amino-1mq-explained)
- [Retatrutide from a lab vial: what independent testing found](https://pepvault.app/guides/retatrutide-lab-vial-tests)
- [Switching from Saxenda to Wegovy: how the change works](https://pepvault.app/guides/saxenda-to-wegovy)
- [Do you stop Ozempic, Wegovy, Mounjaro or Zepbound before surgery?](https://pepvault.app/guides/glp-1-before-surgery)
- [Diarrhea on a GLP-1: how common, and how long it lasts](https://pepvault.app/guides/diarrhea-on-a-glp-1)
- [Dizziness on a GLP-1: dehydration, blood pressure or blood sugar?](https://pepvault.app/guides/dizziness-on-a-glp-1)
- [Heartburn and acid reflux on a GLP-1: the rates, the timing and what helps](https://pepvault.app/guides/heartburn-on-a-glp-1)
- [Does Ozempic or Mounjaro make you tired? Fatigue in the trials](https://pepvault.app/guides/glp-1-fatigue)
- [Can a GLP-1 cause low blood sugar if you do not have diabetes?](https://pepvault.app/guides/glp-1-low-blood-sugar)
- [Is there a medicine for GLP-1 nausea? Tradipitant, so far](https://pepvault.app/guides/tradipitant-for-glp-1-nausea)
- [GLP-1s and mood: depression, anxiety and what the FDA review found](https://pepvault.app/guides/glp-1s-and-mood)
- [Can Ozempic cause vision loss? GLP-1s and NAION, by the numbers](https://pepvault.app/guides/glp-1-and-naion)
- [Are GLP-1s safe long term? What the longest trials show](https://pepvault.app/guides/are-glp-1s-safe-long-term)
- [GLP-1s and the kidneys: what FLOW showed, and the dehydration risk](https://pepvault.app/guides/glp-1s-and-the-kidneys)
- [Can you drink alcohol on Ozempic, Mounjaro or another GLP-1?](https://pepvault.app/guides/alcohol-on-a-glp-1)
- [Do GLP-1s reduce alcohol cravings? What the trials found](https://pepvault.app/guides/glp-1-and-alcohol-cravings)
- [GLP-1s and fatty liver: what the trials measured](https://pepvault.app/guides/glp-1-and-fatty-liver)
- [GLP-1s after a gastric sleeve or bypass: regain, dosing and sleeve vs GLP-1](https://pepvault.app/guides/glp-1-after-bariatric-surgery)
- [Can you drink alcohol on retatrutide?](https://pepvault.app/guides/retatrutide-and-alcohol)
- [Ozempic, Wegovy, Mounjaro or Zepbound not working? Slow responders and plateaus in the trials](https://pepvault.app/guides/glp-1-not-working)
- [Intermittent fasting for weight and fat loss: what the trials measured](https://pepvault.app/guides/intermittent-fasting-weight-loss)
- [Can you take metformin with Ozempic, Mounjaro or another GLP-1?](https://pepvault.app/guides/metformin-with-a-glp-1)
- [GLP-1s and pregnancy: Ozempic, Wegovy, Mounjaro and Zepbound before and during](https://pepvault.app/guides/glp-1s-and-pregnancy)
- [Can you take Ozempic, Mounjaro or another GLP-1 while breastfeeding?](https://pepvault.app/guides/glp-1-while-breastfeeding)
- [Eloralintide, petrelintide and amycretin: the amylin drugs in trials](https://pepvault.app/guides/amylin-drugs-in-trials)
- [Olatorepatide (HS-20094): Regeneron's obesity drug, what is known so far](https://pepvault.app/guides/olatorepatide-explained)
- [Cagrilintide and CagriSema: what amylin adds to semaglutide](https://pepvault.app/guides/cagrilintide-and-cagrisema)
- [Berobenatide (PF-08653944, MET-097i): Pfizer's monthly GLP-1 shot, what is known so far](https://pepvault.app/guides/berobenatide-explained)
- [The GLP-1 pipeline: every drug in phase 2 and 3, and when its trials finish](https://pepvault.app/guides/glp-1-pipeline)
- [Is there a monthly GLP-1 shot? MariTide and berobenatide](https://pepvault.app/guides/monthly-glp-1-shots)
- [Cagrilintide alone: RENEW 1 phase 3 results and what to expect](https://pepvault.app/guides/renew-1-cagrilintide-results)
- [Zenagamtide (amycretin): Novo's GLP-1 and amylin shot and pill, what the trials show](https://pepvault.app/guides/zenagamtide-amycretin)
- [Wegovy and Ozempic price, Medicare and WADA: what changes on January 1, 2027](https://pepvault.app/guides/glp-1-changes-january-2027)
- [Can you take sermorelin with Ozempic, Mounjaro or another GLP-1?](https://pepvault.app/guides/sermorelin-with-a-glp-1)
- [Retatrutide in women: what the studies included](https://pepvault.app/guides/retatrutide-in-women)
- [Peptides for women: what the trials in women show, and after 40](https://pepvault.app/guides/peptides-for-women)
- [Low-dose naltrexone (LDN) for weight loss: what the trials measured](https://pepvault.app/guides/ldn-for-weight-loss)
- [GLP-1s and PCOS: what the trials show, and how they compare with metformin](https://pepvault.app/guides/glp-1-and-pcos)
- [GLP-1s and sleep: insomnia, vivid dreams and the sleep apnea approval](https://pepvault.app/guides/glp-1s-and-sleep)

### Terms on this page

- [Receptor agonist](https://pepvault.app/glossary/receptor-agonist)
- [Half-life](https://pepvault.app/glossary/half-life)
- [Steady state](https://pepvault.app/glossary/steady-state)
- [Maintenance dose](https://pepvault.app/glossary/maintenance-dose)
- [Stack](https://pepvault.app/glossary/stack)
- [GLP-1](https://pepvault.app/glossary/glp-1)
- [Placebo](https://pepvault.app/glossary/placebo)
- [Indication](https://pepvault.app/glossary/indication)

<!--promo-->

PepVault for iPhone

## Keep your protocol in PepVault

Log every dose, track every vial, and see your protocol come together.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?ppid=616838ec-3248-400f-bd58-4b93f85f1a20&pt=129020030&ct=guide-card-sticky&mt=8)

7 days free on the yearly plan for new subscribers.

[Explore the live demo](https://pepvault.app/login)

<!--/promo-->

PepVault is a research and tracking resource, not medical advice. Ranges are what studies used, never a dose for you. Brand names are trademarks of their owners; PepVault is independent of them.

PepVault is a private research and tracking tool, not medical advice. The information here is reference material from published literature and community use — always verify it and discuss any protocol with a qualified clinician before changing it.

© 2026 PepVault. Our text, data and tools may not be copied, scraped or republished without [permission](https://pepvault.app/terms#content).
